LA JOLLA, CA – January 25, 2012 – The Scripps Research Institute has named Professor Peter K. Vogt, PhD, as senior vice president for scientific affairs.
“I’m delighted that Peter has agreed to assume this important new responsibility guiding the academic affairs of the institute and supporting our outstanding faculty,” said Scripps Research President Michael A. Marletta, PhD. “He brings the highest scientific standards, insight, judgment, and dedication to the institute that will be great assets in this position. I very much look forward to working with him.”
Over his career, Vogt has focused on virology, genetics, cell biology, and cancer. Vogt made the fundamental discoveries that led to the identification of oncogenes, which control cell growth and division and lead to carcinogenesis—the process whereby benign cells in the body are transformed into cancerous ones. His work has been recognized by a number of prestigious awards, including election to the American Academy of Arts and Sciences, Institute of Medicine, and the National Academies of Sciences.
Vogt earned a BS from the University of Würzburg (1955) and a PhD from the University of Tübingen (1959). He then became a postdoctoral fellow in the laboratory of Harry Rubin at the University of California, Berkeley, where Vogt began research on the cancer-causing virus, Rous sarcoma virus.
Before arriving at Scripps Research in 1993, he held positions at the University of Colorado Medical School (1962-1967), the University of Washington School of Medicine (1967-1971), and the University of Southern California School of Medicine (1971-1993), where he was Hastings Distinguished Professor and Chairman of the Department of Microbiology.
Vogt’s scientific activities currently include serving on the editorial boards of a number of journals, including Proceedings of the National Academy of Arts and Sciences; Current Topics in Microbiology and Immunology; Blood Cells, Molecules & Diseases; Cell Cycle, Genes and Cancer; OncoTarget; and Frontiers in Molecular and Cellular Oncology.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including two Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
# # #
Office of Communications